[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Argatroban Market Research Report 2012-2024

June 2019 | 85 pages | ID: G8E17C295AFEN
HeyReport

US$ 2,110.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Argatroban Powder
  • Argatroban Injection
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Pfizer
  • SANDOZ
  • GlaxoSmithKline
  • fresenius-kabi
  • Eagle Pharmaceuticals
  • Mitsubishi Tanabe Pharma
  • Teva Pharmaceutical Industries
  • WEST-WARD
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Heparin-induced thrombocytopenia (HIT)
  • Percutaneous Coronary Intervention
  • Cerebral arterial thrombosis
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Argatroban Powder
    1.2.1.2 Argatroban Injection
  1.2.2 by Application
    1.2.2.1 Heparin-induced thrombocytopenia (HIT)
    1.2.2.2 Percutaneous Coronary Intervention
    1.2.2.3 Cerebral arterial thrombosis
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Argatroban Powder Market, 2013-2018
  4.1.2 Argatroban Injection Market, 2013-2018
4.2 Market Forecast
  4.2.1 Argatroban Powder Market Forecast, 2019-2024
  4.2.2 Argatroban Injection Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Heparin-induced thrombocytopenia (HIT) Market, 2013-2018
  5.1.2 Percutaneous Coronary Intervention Market, 2013-2018
  5.1.3 Cerebral arterial thrombosis Market, 2013-2018
5.2 Market Forecast
  5.2.1 Heparin-induced thrombocytopenia (HIT) Market Forecast, 2019-2024
  5.2.2 Percutaneous Coronary Intervention Market Forecast, 2019-2024
  5.2.3 Cerebral arterial thrombosis Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Pfizer
8.2 SANDOZ
8.3 GlaxoSmithKline
8.4 fresenius-kabi
8.5 Eagle Pharmaceuticals
8.6 Mitsubishi Tanabe Pharma
8.7 Teva Pharmaceutical Industries
8.8 WEST-WARD

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Argatroban
Table Products Segment of Argatroban
Table Argatroban Powder Overview
Table Argatroban Injection Overview
Table Global Argatroban Market by Type, 2011-2022 (USD Million)
Table Application Segment of Argatroban
Table Heparin-induced thrombocytopenia (HIT) Overview
Table Percutaneous Coronary Intervention Overview
Table Cerebral arterial thrombosis Overview
Table Global Argatroban Market by Application, 2011-2022 (USD Million)
Table Global Argatroban Market by Region, 2011-2022 (USD Million)
Table Cost of Argatroban
Table Market Dynamics
Table Policy of Argatroban
Table GDP of Major Countries
Table Argatroban Powder CAGR by Revenue and Volume, 2012-2018
Table Argatroban Injection CAGR by Revenue and Volume, 2012-2018
Table Argatroban Powder CAGR by Revenue and Volume, 2012-2024
Table Argatroban Injection CAGR by Revenue and Volume, 2012-2024
Table Heparin-induced thrombocytopenia (HIT) CAGR by Revenue and Volume, 2012-2018
Table Percutaneous Coronary Intervention CAGR by Revenue and Volume, 2012-2018
Table Cerebral arterial thrombosis CAGR by Revenue and Volume, 2012-2018
Table Global Argatroban Market by Vendors, 2012-2018 (USD Million)
Table Global Argatroban Market by Vendors, 2012-2018 (in Volume)
Table Global Argatroban Market Share by Vendors, 2012-2018 (USD Million)
Table Global Argatroban Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SANDOZ Profile List
Table Microecological Modulator Operating Data of SANDOZ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table fresenius-kabi Profile List
Table Microecological Modulator Operating Data of fresenius-kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eagle Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Eagle Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mitsubishi Tanabe Pharma Profile List
Table Microecological Modulator Operating Data of Mitsubishi Tanabe Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table WEST-WARD Profile List
Table Microecological Modulator Operating Data of WEST-WARD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Argatroban Picture
Figure Industry Chain Structure of Argatroban
Figure SWOT of Argatroban
Figure Argatroban Powder Market Size and Growth, 2012-2018 (USD Million)
Figure Argatroban Powder Market Size and Growth, 2012-2018 (in Volume)
Figure Argatroban Injection Market Size and Growth, 2012-2018 (USD Million)
Figure Argatroban Injection Market Size and Growth, 2012-2018 (in Volume)
Figure Argatroban Powder Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Argatroban Powder Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Argatroban Injection Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Argatroban Injection Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Percutaneous Coronary Intervention Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cerebral arterial thrombosis Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Argatroban Market Concentration by Region
Figure Marketing Channels Overview


More Publications